APPENDIX 1 - DEFINITIONS

ABP Documentation Package. As defined in the International Standard for Results Management.

ABP Guidelines. WADA’s Athlete Biological Passport Operating Guidelines and Compilation of Required Elements, as amended by WADA from time to time.

ABP Programme. The programme and methods of gathering and collating biological Markers on a longitudinal basis to facilitate indirect detection of the Use of Prohibited Substances and Prohibited Methods.

ABP Testing. The collection, transportation and analysis of Samples to measure individual blood or urine variables for longitudinal profiling as part of the ABP Programme.

ADAMS. The Anti-Doping Administration and Management System is a Web-based database management tool for data entry, storage, sharing and reporting designed to assist stakeholders and WADA in their anti-doping operations in conjunction with data protection legislation.

Administration. Providing, supplying, supervising, facilitating, or otherwise participating in the Use or Attempted Use by another Person of a Prohibited Substance or Prohibited Method. However, this definition shall not include the actions of bona fide medical personnel involving a Prohibited Substance or Prohibited Method Used for genuine and legal therapeutic purposes or other acceptable justification and shall not include actions involving Prohibited Substances which are not prohibited in Out-of-Competition Testing unless the circumstances as a whole demonstrate that such Prohibited Substances are not intended for genuine and legal therapeutic purposes or are intended to enhance sport performance.

Adverse Analytical Finding. A report from a WADA-accredited laboratory or other WADA-approved laboratory that, consistent with the International Standard for Laboratories, establishes in a Sample the presence of a Prohibited Substance or its Metabolites or Markers (including elevated quantities of endogenous substances) or evidence of the Use of a Prohibited Method.

Adverse Passport Finding. A report identified as an Adverse Passport Finding as described in the applicable International Standards.

Aggravating Circumstances. Circumstances involving, or actions by, a Player or other Person which may justify the imposition of a period of Ineligibility greater than the standard sanction. Such circumstances and actions shall include, but are not limited to: the Player or other Person Used or Possessed multiple Prohibited Substances or Prohibited Methods, Used or Possessed a Prohibited Substance or Prohibited Method on multiple occasions or committed multiple other anti-doping rule violations; a normal individual would be likely to enjoy the performance-enhancing effects of the anti-doping rule violation(s) beyond the otherwise applicable period of Ineligibility; the Player or Person engaged in deceptive or obstructive conduct to avoid the detection or adjudication of an anti-doping rule violation; or the Player or other Person engaged in Tampering during Results Management. For the avoidance of doubt, the examples of circumstances and conduct described herein are not exclusive and other similar circumstances or conduct may also justify the imposition of a longer period of Ineligibility.

Anti-Doping Activities. Anti-doping Education and information, test distribution planning, maintenance of a Registered Testing Pool, managing Athlete Biological Passports, conducting Testing, organizing analysis of Samples, gathering of intelligence and conduct of investigations, processing of TUE applications, Results Management, monitoring and enforcing compliance with any Consequences imposed, and all other activities related to anti-doping to be carried out by or on behalf of an Anti-Doping Organization, as set out in the Code and/or the International Standards.

Anti-Doping Manager. An appointee of the ICC with supervisory responsibilities in relation to the ICC Code, or his/her designee.

Anti-Doping Organisation. WADA or a Signatory that is responsible for adopting rules for initiating, implementing or enforcing any part of the Doping Control process. This includes, for example, the International Olympic Committee, the International Paralympic Committee, other Major Event Organisations that conduct Testing at their Events, International Federations such as the ICC, and National Anti-Doping Organisations.

Anti-Doping Panel. As defined in Article 8.1.1.

Anti-Doping Tribunal. A panel of three persons (subject to Article 8.1.7) appointed by the ICC consisting of a Chair (who shall be legally qualified), and other lawyers and/or a medical expert and/or a technical expert with experience in anti-doping, to perform the functions assigned to the Anti-Doping Tribunal under the ICC Code. Each member of the Anti-Doping Tribunal shall be independent of the ICC, which may provide reasonable compensation and reimbursement of expenses to such members. The Anti-Doping Tribunal shall be Operationally Independent.

Athlete. Any Person who competes in sport at the international level (as defined by each International Federation) or the national level (as defined by each National Anti-Doping Organization). An Anti-Doping Organization has discretion to apply anti-doping rules to an Athlete who is neither an International-Level Athlete nor a National-Level Athlete, and thus to bring them within the definition of “Athlete”. In relation to Athletes who are neither International-Level nor National-Level Athletes, an Anti-Doping Organization may elect to: conduct limited Testing or no Testing at all; analyze Samples for less than the full menu of Prohibited Substances; require limited or no whereabouts information; or not require advance TUEs. However, if an Article 2.1, 2.3 or 2.5 anti-doping rule violation is committed by any Athlete over whom an Anti-Doping Organization has elected to exercise its authority to test and who competes below the international or national level, then the Consequences set forth in the Code must be applied. For purposes of Article 2.8 and Article 2.9 and for purposes of anti-doping information and Education, any Person who participates in sport under the authority of any Signatory, government, or other sports organization accepting the Code is an Athlete.

Athlete Biological Passport. The programme and methods of gathering and collating data as described in the International Standard for Testing and Investigations and International Standard for Laboratories.

Athlete Biological Passport Management Unit or ABPMU. As defined in the International Standard for Laboratories.

Attempt. Purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an anti-doping rule violation. Provided, however, there shall be no anti- doping rule violation based solely on an Attempt to commit a violation if the Person renounces the Attempt prior to it being discovered by a third party not involved in the Attempt. Attempted shall be construed accordingly.

Atypical Passport Finding. A report described as an Atypical Passport Finding as described in the applicable International Standards.

Atypical Finding. A report from a WADA-accredited laboratory or other WADA-approved laboratory which requires further investigation as provided by the International Standard for Laboratories or related technical documents prior to the determination of an Adverse Analytical Finding

CAS. The Court of Arbitration for Sport in Lausanne, Switzerland.

Code. The 2021 World Anti-Doping Code.

Competition. A single race, match, game or singular sport contest.

Consequences of Anti-Doping Rule Violations (“Consequences”). An anti-doping rule violation may result in one or more of the following: (a) Disqualification means the Player’s individual results in a particular International Match are invalidated, with all resulting Consequences, including forfeiture of any individual medals or other prizes awarded; (b) Ineligibility means the Player or other Person is barred on account of an anti-doping rule violation for a specified period of time from participation in any Competition or other activity or funding as provided in Article 10.14.1.1 of the ICC Code; (c) Provisional Suspension means the Player or other Person is temporarily barred from participating in the sport of cricket or in any Competition or activity pending a decision on the allegation that he/she has committed an anti-doping rule violation ; (d) Financial Consequences means a financial sanction imposed for an anti-doping rule violation or to recover costs associated with an anti-doping rule violation; and (e) Public Disclosure means the dissemination or distribution of information to the general public or Persons beyond Persons entitled to earlier notification in accordance with Article 14. Teams may also be subject to Consequences as provided in Article 11.

Contaminated Product. A product that contains a Prohibited Substance that is not disclosed on the product label or in the information available in a reasonable Internet search.

Cricket Testing Protocols. The Cricket Testing Protocols developed by the ICC to supplement the International Standard for Testing and Investigations, as they may be amended from time to time.

Decision Limit. The value of the result for a threshold substance in a Sample, above which an Adverse Analytical Finding shall be reported, as defined in the International Standard for Laboratories.

Delegated Third Party. Any Person to which the ICC delegates any aspect of Doping Control or anti-doping Education programs including, but not limited to, National Cricket Federations, third parties or other Anti- Doping Organizations that conduct Sample collection or other Doping Control services or anti-doping Educational programs for the ICC, or individuals serving as independent contractors who perform Doping Control services for the ICC (e.g., non-employee Doping Control officers or chaperones). This definition does not include CAS.

Demand. As defined in Article 7.6.3.1.

Disqualification. See Consequences, above.

Domestic Match. Any ‘First-Class Match’, ‘List A Limited Overs Match’ or ‘List A Twenty20 Match’ and/or any ‘Other Match’ played under the sole control and auspices of a National Cricket Federation and/or classified as Official Cricket by such National Cricket Federation, as those terms are defined in the ICC Classification of Official Cricket (as amended from time to time).

Doping Control. All steps and processes from test distribution planning through to ultimate disposition of any appeal and the enforcement of Consequences, including all steps and processes in between, including but not limited to Testing, investigations, whereabouts, TUEs, Sample collection and handling, laboratory analysis, Results Management and investigations or proceedings relating to violations of Article 10.14 (Status During Ineligibility or Provisional Suspension).

Education. The process of learning to instill values and develop behaviors that foster and protect the spirit of sport, and to prevent intentional and unintentional doping.

Effective Date. As defined in Article 18.5.

Event. A series of individual Competitions conducted together under one ruling body.

Event Period: For the purposes of the Code, the Event Period shall be deemed to start and end at the same times as the In-Competition period as set out in Article 5.2.2.

Event Venue: For the purposes of the Code, those venues so designated by the ruling body for the Match or Event.

Expert Panel. as defined in the International Standard for Results Management.

Fault. Fault is any breach of duty or any lack of care appropriate to a particular situation. Factors to be taken into consideration in assessing a Player or other Person’s degree of Fault include, for example, the Player’s or other Person’s experience, whether the Player or other Person is a Protected Person, special considerations such as impairment, the degree of risk that should have been perceived by the Player and the level of care and investigation exercised by the Player in relation to what should have been the perceived level of risk. In assessing the Player or other Person’s degree of Fault, the circumstances considered must be specific and relevant to explain the Player’s or other Person’s departure from the expected standard of behavior. Thus, for example, the fact that a Player would lose the opportunity to earn large sums of money during a period of Ineligibility, or the fact that the Player only has a short time left in his or her career, or the timing of the sporting calendar, would not be relevant factors to be considered in reducing the period of Ineligibility under Article 10.6.1 or 10.6.2.

Filing Failure. As defined in the International Standard for Results Management.

Financial Consequences. See Consequences, above.

Hearing Panel. Any hearing panel appointed/established under the ICC Code to hear and determine an allegation that an anti-doping rule violation has been committed, or any appeal of such matter, including the Anti-Doping Tribunal and any hearing panel appointed by CAS to hear appeals under Article 13.

ICC. The International Cricket Council or its designee.

ICC Classification of Official Cricket. The ICC’s Classification of Official Cricket, as amended from time to time.

ICC Events. Each of the following (in men’s and women’s cricket): (a) the ICC Cricket World Cup; (b) the ICC World Twenty20; (c) the ICC Under 19 Cricket World Cup; (d) the ICC World Cup Qualifying Tournament; (e) the ICC World Twenty20 Qualifying Tournament; and (f) any other event organised or sanctioned by the ICC from time to time to which the ICC deems it appropriate that the ICC Code should apply, provided that the ICC has given at least three months’ notice to all National Cricket Federations participating in such event that it is to be deemed an ICC Event for the purposes of the ICC Code.

In-Competition. The period described in Article 5.2.2.

Independent Review Board. A standing panel appointed by the ICC, consisting of persons with medical, technical and/or legal experience in anti-doping, to perform the functions assigned to the Independent Review Board in the ICC Code. Further persons may be included onto the Independent Review Board on a case-by-case basis, where there is a need for their specific expertise and/or experience. Each member of the Independent Review Board panel shall be independent of the ICC, which may provide reasonable compensation and reimbursement of expenses to such members.

Ineligibility. See Consequences, above.

Institutional Independence. Hearing panels on appeal shall be fully independent institutionally from the Anti- Doping Organization responsible for Results Management. They must therefore not in any way be administered by, connected or subject to the Anti-Doping Organization responsible for Results Management.

International Event. An Event or Competition where the International Olympic Committee, the International Paralympic Committee, an International Federation, a Major Event Organisation, or another international sport organisation is the ruling body for the Event or appoints the technical officials for the Event.

International-Level Player: As defined in Article 1.1.

International Match. International Match. Each of the following (in men’s and women’s cricket): (a) any Test Match, One Day International Match or Twenty20 International Match; (b) any Match played as part of an ICC Event; (c) any other Match played between representative sides of any National Cricket Federation at Under 19 level or above; (d) any International Tour Match; and (e) any other Match organised or sanctioned by the ICC from time to time to which the ICC deems it appropriate that the Anti-Doping Code should apply.

International Registered Testing Pool or IRTP. As defined in Article 5.3.2.1.

International Standard. A standard adopted by WADA in support of the Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly. The International Standards shall include any Technical Documents issued pursuant to the International Standard.

Major Event Organisations. The continental associations of National Olympic Committees and other international multi-sport organisations that function as the ruling body for any continental, regional or other International Event.

Marker. A compound, group of compounds or biological variable(s) that indicates the Use of a Prohibited Substance or Prohibited Method.

Match. A cricket match of any format and duration in length in which two cricket teams compete against each other.

Metabolite. Any substance produced by a biotransformation process.

Minor. A natural Person who has not reached the age of eighteen years.

Missed Test. As defined in the International Standard for Results Management

National Anti-Doping Organisation or NADO. The entity(ies) designated by each country as possessing the primary authority and responsibility to adopt and implement anti-doping rules, direct the collection of Samples, manage test results, and conduct Results Management at the national level. If this designation has not been made by the competent public authority (ies), the entity shall be the country's National Olympic Committee or its designee.

National Cricket Federation. A national or regional entity which is a member of or is recognised by the ICC as the entity governing the sport of cricket in a country (or collective group of countries associated for cricket purposes).

National Level Athlete. Athletes who compete in sport at the national level, as defined by each National Anti-Doping Organization, consistent with the International Standard for Testing and Investigations.

National Cricket Federation Pool. As defined in Article 5.3.3.3.

National Event. A sport Event or Competition involving International- or National-Level Athletes that is not an International Event.

National Olympic Committee. The organisation recognised in each country by the International Olympic Committee. The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti-doping area.

National Player Pool. As defined in Article 5.3.3.3.

No Advance Notice. Sample collection which takes place with no advance warning to the Player and where the Player is continuously chaperoned from the moment of notification through Sample provision.

No Fault or Negligence. The Player or other Person’s establishing that he/she did not know or suspect, and could not reasonably have known or suspected even with the exercise of utmost caution, that he/she had Used or been administered the Prohibited Substance or Prohibited Method or otherwise violated an anti-doping rule. Except in the case of a Protected Person or Recreational Athlete, for any violation of Article 2.1, the Player must also establish how the Prohibited Substance entered his or her system.

No Significant Fault or Negligence. The Player or other Person’s establishing that his/her Fault or Negligence, when viewed in the totality of the circumstances and taking into account the criteria for No Fault or Negligence, was not significant in relationship to the anti-doping rule violation. Except in the case of a Protected Person or Recreational Athlete, for any violation of Article 2.1, the Player must also establish how the Prohibited Substance entered his or her system.

Notice of Charge. As defined in Article 7.9.

Notification. As defined in Article 7.1.3.

One Day International Match. As defined by the ICC Classification of Official Cricket, as it may be amended from time to time.

Operational Independence. This means that (1) board members, staff members, commission members, consultants and officials of the Anti-Doping Organization with responsibility for Results Management or its affiliates (e.g., member federation or confederation), as well as any Person involved in the investigation and pre-adjudication of the matter cannot be appointed as members and/or clerks (to the extent that such clerk is involved in the deliberation process and/or drafting of any decision) of hearing panels of that Anti-Doping Organization with responsibility for Results Management and (2) hearing panels shall be in a position to conduct the hearing and decision-making process without interference from the Anti-Doping Organization or any third party. The objective is to ensure that members of the hearing panel or individuals otherwise involved in the decision of the hearing panel, are not involved in the investigation of, or decisions to proceed with, the case.

Out-of-Competition. Any period that is not In-Competition.

Person. A natural Person or an organisation or other entity.

Player. As defined in Article 1.1.

Player Support Personnel. As defined in Article 1.4.

Possession. Actual, physical Possession, or the constructive Possession (which shall be found only if the Person has exclusive control or intends to exercise control over the Prohibited Substance/Method or the premises in which a Prohibited Substance/Method exists); provided, however, that if the Person does not have exclusive control over the Prohibited Substance/Method or the premises in which a Prohibited Substance/Method exists, constructive Possession shall only be found if the Person knew about the presence of the Prohibited Substance/Method and intended to exercise control over it. Provided, however, there shall be no anti-doping rule violation based solely on Possession if, prior to receiving notification of any kind that the Person has committed an anti-doping rule violation, the Person has taken concrete action demonstrating that the Person never intended to have Possession and has renounced Possession by explicitly declaring it to an Anti-Doping Organisation. Notwithstanding anything to the contrary in this definition, the purchase (including by any electronic or other means) of a Prohibited Substance or Prohibited Method constitutes Possession by the Person who makes the purchase.

Prohibited List. The list identifying the Prohibited Substances and Prohibited Methods.

Prohibited Method. Any method so described on the Prohibited List.

Prohibited Substance. Any substance, or class of substances, so described on the Prohibited List.

Protected Person. A Player or other natural Person who at the time of the anti-doping rule violation: (i) has not reached the age of sixteen (16) years; (ii) has not reached the age of eighteen (18) years and is not included in any Registered Testing Pool and has never competed in any International Event in an open category; or (iii) for reasons other than age has been determined to lack legal capacity under applicable national legislation.

Provisional Hearing. For purposes of Article 7.8, an expedited abbreviated hearing occurring prior to a hearing under Article 8 that provides the Player or other Person with notice and an opportunity to be heard in either written or oral form.

Provisional Suspension. See Consequences, above.

Publicly Disclose. See Consequences, above.

Recreational Athlete. A natural Person who is so defined by the relevant National Anti-Doping Organization; provided, however, the term shall not include any Person who, within the five (5) years prior to committing any anti-doping rule violation, has been an International-Level Athlete (as defined by each International Federation consistent with the International Standard for Testing and Investigations) or National-Level Athlete (as defined by each National Anti-Doping Organization consistent with the International Standard for Testing and Investigations), has represented any country in an International Event in an open category or has been included within any Registered Testing Pool or other whereabouts information pool maintained by any International Federation or National Anti-Doping Organization.

Regional Anti-Doping Organisation. A regional entity designated by member countries to coordinate and manage delegated areas of their national anti-doping programs, which may include the adoption and implementation of anti-doping rules, the planning and collection of Samples, the management of results, the review of TUEs, the conduct of hearings, and the conduct of Educational programs at a regional level.

Registered Testing Pool. The pool of highest-priority Athletes established separately at the international level by International Federations and at the national level by National Anti-Doping Organizations, who are subject to focused In-Competition and Out-of-Competition Testing as part of that International Federation's or National Anti-Doping Organization's test distribution plan and therefore are required to provide whereabouts information as provided in Article 5.5 and the International Standard for Testing and Investigations.

Results Management. The process encompassing the timeframe between notification as per Article 5 of the International Standard for Results Management, or in certain cases (e.g., Atypical Finding, Athlete Biological Passport, whereabouts failure), such pre-notification steps expressly provided for in Article 5 of the International Standard for Results Management, through the charge until the final resolution of the matter, including the end of the hearing process at first instance or on appeal (if an appeal was lodged).

Sample or Specimen. Any biological material collected for the purposes of Doping Control.  

Sample. Those entities accepting the Code and agreeing to implement the Code, as provided in Article 23 of the Code.

Signatories. Those entities accepting the Code and agreeing to implement the Code, as provided in Article 23 of the Code.

Specified Method. As defined in Article 4.1.2

Specified Substances. As defined in Article 4.1.2.

Strict Liability. The rule which provides that under Article 2.1 and Article 2.2, it is not necessary that intent, Fault, Negligence, or knowing Use on the Athlete’s part be demonstrated by the Anti-Doping Organization in order to establish an anti-doping rule violation.

Substance of Abuse. See Article 4.1.3.

Substantial Assistance. For purposes of Article 10.7.1 a Person providing Substantial Assistance must: (a) fully disclose in a signed written statement or recorded interview all information that he/she possesses in relation to anti-doping rule violations or other proceedings as described in Article 10.7.1.1; and (b) fully cooperate with the investigation and adjudication of any case or matter related to that information, including, for example, presenting testimony at a hearing if requested to do so by the ICC, an Anti-Doping Organisation or hearing panel. Further, the information provided must be credible and must comprise an important part of any case or proceeding that is initiated or, if no case or proceeding is initiated, must have provided a sufficient basis on which a case or proceeding could have been brought.

Tampering. Intentional conduct which subverts the Doping Control process but which would not otherwise be included in the definition of Prohibited Methods. Tampering shall include, without limitation, offering or accepting a bribe to perform or fail to perform an act, preventing the collection of a Sample, affecting or making impossible the analysis of a Sample, falsifying documents submitted to an Anti-Doping Organization or TUE committee or hearing panel, procuring false testimony from witnesses, committing any other fraudulent act upon the Anti-Doping Organization or hearing body to affect Results Management or the imposition of Consequences, and any other similar intentional interference or Attempted interference with any aspect of Doping Control.

Target Testing. Selection of specific Players for Testing based on criteria set forth in the International Standard for Testing and Investigations.

Technical Document. A document adopted and published by WADA from time to time containing mandatory technical requirements on specific anti-doping topics as set forth in an International Standard.

Testing. The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to the laboratory.

Testing Authority. As defined in Article 3.5 of the International Standard for Testing and Investigations.

Test Matches. As defined by the ICC Classification of Official Cricket, as it may be amended from time to time.

Trafficking. Selling, giving, administering, transporting, sending, delivering or distributing (or Possessing for any such purpose) a Prohibited Substance or Prohibited Method (either physically or by any electronic or other means) by a Player or other Person subject to the jurisdiction of an Anti-Doping Organisation to any third party; provided, however, that this definition shall not include (a) the actions of bona fide medical personnel involving a Prohibited Substance used for genuine and legal therapeutic purposes or other acceptable justification; or (b) actions involving Prohibited Substances which are not prohibited in Out-ofCompetition Testing unless the circumstances as a whole demonstrate such Prohibited Substances were not intended for genuine and legal therapeutic purposes or are intended to enhance sport performance.

Therapeutic Use Exemption (TUE). A Therapeutic Use Exemption allows a Player with a medical condition to Use a Prohibited Substance or Prohibited Method, but only if the conditions set out in Article 4.4 and the International Standard for Therapeutic Use Exemptions are met.

Trafficking. Selling, giving, transporting, sending, delivering or distributing (or Possessing for any such purpose) a Prohibited Substance or Prohibited Method (either physically or by any electronic or other means) by a Player, Player Support Person or other Person subject to the authority of an Anti-Doping Organisation to any third party; provided, however, that this definition shall not include (a) the actions of bona fide medical personnel involving a Prohibited Substance Used for genuine and legal therapeutic purposes or other acceptable justification; or (b) actions involving Prohibited Substances which are not prohibited in Out-of-Competition Testing unless the circumstances as a whole demonstrate such Prohibited Substances were not intended for genuine and legal therapeutic purposes or are intended to enhance sport performance.

TUE Commitee. A panel appointed by the ICC and composed of at least three physicians with a sound knowledge of clinical and exercise medicine. In all cases involving a Player with a disability, one of the physicians must have experience with the care and treatment of Players with disabilities.

Twenty20 International Matches. As defined by the ICC Classification of Official Cricket, as it may be amended from time to time.

Unsuccessful Attempt Form. As defined in Article 3.5 of the International Standard for Testing and Investigations.

Use. The utilisation, application, ingestion, injection or consumption by any means whatsoever of any Prohibited Substance or Prohibited Method. Used shall be construed accordingly.

WADA. The World Anti-Doping Agency.

Without Prejudice Agreement. For purposes of Articles 10.7.1.1 and 10.8.2, a written agreement between an Anti-Doping Organization and an Athlete/Player or other Person that allows the Athlete/Player or other Person to provide information to the Anti-Doping Organization in a defined time-limited setting with the understanding that, if an agreement for Substantial Assistance or a case resolution agreement is not finalized, the information provided by the Athlete/Player or other Person in this particular setting may not be used by the Anti-Doping Organization against the Athlete/Player or other Person in any Results Management proceeding under the Code, and that the information provided by the Anti-Doping Organization in this particular setting may not be used by the Athlete/Player or other Person against the Anti-Doping Organization in any Results Management proceeding under the Code. Such an agreement shall not preclude the Anti-Doping Organization, Athlete/Player or other Person from using any information or evidence gathered from any source other than during the specific time-limited setting described in the agreement.

Whereabouts Failures. As defined in Article 2.4.

APPENDIX 2 - THE PROHIBITED LIST

At any given time, the current version of the Prohibited List is available on the anti-doping section of the ICC’s website at the following address:

www.icc-cricket.com

IMPORTANT NOTE: the Prohibited List is updated annually, with effect from 1 January each year. All Players and other Persons should therefore review the new Prohibited List (available on the ICC’s website each year) every year in the lead up to 1 January to ensure that anything they ingest or use, as well as any medical treatment they receive, does not give rise to an anti-doping rule violation under the ICC Code